The Relationship Between Immune and Cognitive Dysfunction in Mood and Psychotic Disorder: a Systematic Review and a Meta-analysis

Overview

Journal Mol Psychiatry

Specialties Molecular Biology
Psychiatry

Date 2022 Apr 28

PMID 35484245

Authors

M Morrens

C Overloop

V Coppens

E Loots

M Van Den Noortgate

S Vandenameele

M Leboyer

L De Picker

Affiliations

Soon will be listed here.

Abstract

Background: In psychotic and mood disorders, immune alterations are hypothesized to underlie cognitive symptoms, as they have been associated with elevated blood levels of inflammatory cytokines, kynurenine metabolites, and markers of microglial activation. The current meta-analysis synthesizes all available clinical evidence on the associations between immunomarkers (IMs) and cognition in these psychiatric illnesses.

Methods: Pubmed, Web of Science, and Psycinfo were searched for peer-reviewed studies on schizophrenia spectrum disorder (SZ), bipolar disorder (BD), or major depressive disorder (MDD) including an association analysis between at least one baseline neuropsychological outcome measure (NP) and one IM (PROSPERO ID:CRD42021278371). Quality assessment was performed using BIOCROSS. Correlation meta-analyses, and random effect models, were conducted in Comprehensive Meta-Analysis version 3 investigating the association between eight cognitive domains and pro-inflammatory and anti-inflammatory indices (PII and AII) as well as individual IM.

Results: Seventy-five studies (n = 29,104) revealed global cognitive performance (GCP) to be very weakly associated to PII (r = -0.076; p = 0.003; I = 77.4) or AII (r = 0.067; p = 0.334; I = 38.0) in the combined patient sample. Very weak associations between blood-based immune markers and global or domain-specific GCP were found, either combined or stratified by diagnostic subgroup (GCP x PII: SZ: r = -0.036, p = 0.370, I = 70.4; BD: r = -0.095, p = 0.013, I = 44.0; MDD: r = -0.133, p = 0.040, I = 83.5). We found evidence of publication bias.

Discussion: There is evidence of only a weak association between blood-based immune markers and cognition in mood and psychotic disorders. Significant publication and reporting biases were observed and most likely underlie the inflation of such associations in individual studies.

Citing Articles

Immune-neuroendocrine crosstalk in mood and psychotic disorders: A meta-analysis and systematic review.

Den Noortgate M, Van Den Eede F, Coppens V, Giltay E, De Picker L, Morrens M Brain Behav Immun Health. 2025; 44:100965.

PMID: 40040865 PMC: 11879693. DOI: 10.1016/j.bbih.2025.100965.

Telomere Dynamics in Post-Traumatic Stress Disorder: A Critical Synthesis.

Rajkumar R Biomedicines. 2025; 13(2).

PMID: 40002919 PMC: 11853385. DOI: 10.3390/biomedicines13020507.

Depressive and Negative Symptoms in the Early and Established Stages of Schizophrenia: Integrating Structural Brain Alterations, Cognitive Performance, and Plasma Interleukin 6 Levels.

Corsi-Zuelli F, Donohoe G, Griffiths S, Del-Ben C, Watson A, Burke T Biol Psychiatry Glob Open Sci. 2025; 5(2):100429.

PMID: 39911538 PMC: 11795630. DOI: 10.1016/j.bpsgos.2024.100429.

Inflammation and cognitive performance in elite athletes: A cross-sectional study.

Wiedenbrug K, Will L, Reichert L, Hacker S, Lenz C, Zentgraf K Brain Behav Immun Health. 2025; 42:100872.

PMID: 39881815 PMC: 11776080. DOI: 10.1016/j.bbih.2024.100872.

Altered brain regional homogeneity, depressive symptoms, and cognitive impairments in medication-free female patients with current depressive episodes in bipolar disorder and major depressive disorder.

Ni S, Peng T, Gao S, Ling C, Wu F, Jiang J BMC Psychiatry. 2024; 24(1):892.

PMID: 39643889 PMC: 11622491. DOI: 10.1186/s12888-024-06352-4.

References

Plaven-Sigray P, Matheson G, Coughlin J, Hafizi S, Laurikainen H, Ottoy J . Meta-analysis of the Glial Marker TSPO in Psychosis Revisited: Reconciling Inconclusive Findings of Patient-Control Differences. Biol Psychiatry. 2020; 89(3):e5-e8. PMC: 7899168. DOI: 10.1016/j.biopsych.2020.05.028. View

Bora E . Peripheral inflammatory and neurotrophic biomarkers of cognitive impairment in schizophrenia: a meta-analysis. Psychol Med. 2019; 49(12):1971-1979. DOI: 10.1017/S0033291719001685. View

Chakrabarty T, Torres I, Bond D, Yatham L . Inflammatory cytokines and cognitive functioning in early-stage bipolar I disorder. J Affect Disord. 2018; 245:679-685. DOI: 10.1016/j.jad.2018.11.018. View

Rock P, Roiser J, Riedel W, Blackwell A . Cognitive impairment in depression: a systematic review and meta-analysis. Psychol Med. 2013; 44(10):2029-40. DOI: 10.1017/S0033291713002535. View

Sanchez-Autet M, Arranz B, Safont G, Sierra P, Garcia-Blanco A, de la Fuente L . Gender differences in C-reactive protein and homocysteine modulation of cognitive performance and real-world functioning in bipolar disorder. J Affect Disord. 2018; 229:95-104. DOI: 10.1016/j.jad.2017.12.038. View

Morrens M, De Picker L, Kampen J, Coppens V . Blood-based kynurenine pathway alterations in schizophrenia spectrum disorders: A meta-analysis. Schizophr Res. 2020; 223:43-52. DOI: 10.1016/j.schres.2020.09.007. View

Prins B, Abbasi A, Wong A, Vaez A, Nolte I, Franceschini N . Investigating the Causal Relationship of C-Reactive Protein with 32 Complex Somatic and Psychiatric Outcomes: A Large-Scale Cross-Consortium Mendelian Randomization Study. PLoS Med. 2016; 13(6):e1001976. PMC: 4915710. DOI: 10.1371/journal.pmed.1001976. View

North H, Bruggemann J, Cropley V, Swaminathan V, Sundram S, Lenroot R . Increased peripheral inflammation in schizophrenia is associated with worse cognitive performance and related cortical thickness reductions. Eur Arch Psychiatry Clin Neurosci. 2021; 271(4):595-607. DOI: 10.1007/s00406-021-01237-z. View

Elderkin-Thompson V, Irwin M, Hellemann G, Kumar A . Interleukin-6 and memory functions of encoding and recall in healthy and depressed elderly adults. Am J Geriatr Psychiatry. 2012; 20(9):753-63. PMC: 3690956. DOI: 10.1097/JGP.0b013e31825d08d6. View

10.

Vreeker A, van Bergen A, Kahn R . Cognitive enhancing agents in schizophrenia and bipolar disorder. Eur Neuropsychopharmacol. 2015; 25(7):969-1002. DOI: 10.1016/j.euroneuro.2015.04.014. View

11.

Wu J, Chen D, Tan Y, Tan S, Xiu M, Wang Z . Altered interleukin-18 levels are associated with cognitive impairment in chronic schizophrenia. J Psychiatr Res. 2016; 76:9-15. DOI: 10.1016/j.jpsychires.2016.01.013. View

12.

Klaus F, Mitchell K, Liou S, Eyler L, Nguyen T . Chemokine MCP1 is associated with cognitive flexibility in schizophrenia: A preliminary analysis. J Psychiatr Res. 2021; 138:139-145. PMC: 8192469. DOI: 10.1016/j.jpsychires.2021.04.007. View

13.

Peterson R, Brown S . On the use of beta coefficients in meta-analysis. J Appl Psychol. 2005; 90(1):175-81. DOI: 10.1037/0021-9010.90.1.175. View

14.

Zhou Y, Zheng W, Liu W, Wang C, Zhan Y, Li H . Cross-sectional relationship between kynurenine pathway metabolites and cognitive function in major depressive disorder. Psychoneuroendocrinology. 2018; 101:72-79. DOI: 10.1016/j.psyneuen.2018.11.001. View

15.

Miller G, White S, Chen E, Nusslock R . Association of Inflammatory Activity With Larger Neural Responses to Threat and Reward Among Children Living in Poverty. Am J Psychiatry. 2020; 178(4):313-320. PMC: 8016707. DOI: 10.1176/appi.ajp.2020.20050635. View

16.

Xiu M, Tian L, Chen S, Tan Y, Chen D, Chen J . Contribution of IL-10 and its -592 A/C polymorphism to cognitive functions in first-episode drug-naive schizophrenia. Brain Behav Immun. 2016; 57:116-124. DOI: 10.1016/j.bbi.2016.03.005. View

17.

Vinberg M, Weikop P, Olsen N, Kessing L, Miskowiak K . Effect of recombinant erythropoietin on inflammatory markers in patients with affective disorders: A randomised controlled study. Brain Behav Immun. 2016; 57:53-57. DOI: 10.1016/j.bbi.2016.05.006. View

18.

Ferrer A, Labad J, Salvat-Pujol N, Monreal J, Urretavizcaya M, Crespo J . Hypothalamic-pituitary-adrenal axis-related genes and cognition in major mood disorders and schizophrenia: a systematic review. Prog Neuropsychopharmacol Biol Psychiatry. 2020; 101:109929. DOI: 10.1016/j.pnpbp.2020.109929. View

19.

Zazula R, Dodd S, Dean O, Berk M, Bortolasci C, Verri Jr W . Cognition-immune interactions between executive function and working memory, tumour necrosis factor-alpha (TNF-alpha) and soluble TNF receptors (sTNFR1 and sTNFR2) in bipolar disorder. World J Biol Psychiatry. 2021; 23(1):67-77. DOI: 10.1080/15622975.2021.1925152. View

20.

Altendahl M, Maillard P, Harvey D, Cotter D, Walters S, Wolf A . An IL-18-centered inflammatory network as a biomarker for cerebral white matter injury. PLoS One. 2020; 15(1):e0227835. PMC: 6980497. DOI: 10.1371/journal.pone.0227835. View